IART logo

IART

Profile

Full Name

Integra LifeSciences Holdings Corporation

Ticker Symbol

IART

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

August 16, 1995

Indexes

Not included

Website

http://www.integralife.com

Employees

4396

Key Details

Price

$16.18(+0.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.61B(+4.47% YoY)

Annual EPS

-$0.09(-110.71% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$16.18
IART price is $16.18

30-Day Relative Volume

1.11
IART 30-day relative volume is 1.11

Price Performance

Price Today change

+0.59%
IART price is up +0.59% today

Price YTD change

-28.68%
IART price is down -28.68% since January 1st

Price 1-year change

-49.17%
IART price is down -49.17% year-on-year

Price 3-year change

-74.19%
IART price is down -74.19% over the past 3 years

Price Range

Price All-time high

$77.40
IART price is currently -79.10% below its historical high of $77.40

Price 3-year low

$15.95
IART price is currently +1.41% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.25B
IART market capitalization is $1.25 billion

Market cap 3-year change

-76.03%
IART market capitalization is down -76.03% over the past 3 years

Market cap All-time high

$6.48B
IART market capitalization is currently -80.72% below its historical high of $6.48 billion

Market cap sector rank

78.95%
IART market capitalization is higher than 78.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.94%
IART shares outstanding is down -1.94% year-on-year

Shares Outstanding 3-Year Change

-7.11%
IART shares outstanding is down -7.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
IART beta is 0.74

200-day SMA

$22.64
IART price is currently -28.55% below its 200-day simple moving average

50-day SMA

$22.23
IART price is currently -27.22% below its 50-day simple moving average

RSI

24.48
IART 14-day relative strength index is 24.48

Volume

1.11
IART 30-day relative volume is 1.11

ATR

$1.27
IART average true range is $1.27

10-day Historical Volatility

74.15%
IART 10-day historical volatility is 74.15%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.61B
IART annual revenue is $1.61 billion

Revenue Analysts estimate

$1.68B
IART annual revenue is currently -4.10% lower than the consensus analysts' forecast

Revenue 1-year change

+4.47%
IART annual revenue is up +4.47% year-on-year

Revenue Sector rank

83.69%
IART annual revenue is higher than 83.69% of companies in Healthcare sector

EPS

EPS

-$0.09
IART annual earnings per share is -$0.09

EPS Analysts estimate

$2.46
IART annual earnings per share is currently -103.66% lower than the consensus analysts' forecast

EPS 1-year change

-110.71%
IART annual earnings per share is down -110.71% year-on-year

EPS Sector rank

80.53%
IART annual earnings per share is higher than 80.53% of companies in Healthcare sector

Profit

Gross profit

$882.06M
IART annual gross profit is $882.06 million

Gross margin

54.77%
IART annual gross profit margin is 54.77%

Operating profit

$28.41M
IART annual operating income is $28.41 million

Operating margin

1.76%
IART annual operating profit margin is 1.76%

Net income

-$6.94M
IART annual net profit is -$6.94 million

Net margin

-0.43%
IART annual net profit margin is -0.43%

Expenses

Total expenses

$1.58B
IART annual total expenses is $1.58 billion

Operating expenses

$853.65M
IART annual total operating expenses is $853.65 million

Cost of goods sold

$728.47M
IART annual cost of goods sold is $728.47 million

Selling, general & administrative expenses

$716.98M
IART annual SGA is $716.98 million

Depreciation and amortization

$140.89M
IART annual depreciation & amortization is $140.89 million

Interest expense

$70.63M
IART annual interest expense is $70.63 million

Income tax

-$11.29M
IART annual income tax is -$11.29 million

EBIT & EBITDA

EBIT

$52.40M
IART annual earnings before interest & taxes is $52.40 million

EBITDA

$193.29M
IART annual EBITDA is $193.29 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.04B
IART annual total assets is $4.04 billion

Non current assets

$2.96B
IART annual long term assets is $2.96 billion

Current assets

$1.08B
IART annual total current assets is $1.08 billion

Cash and cash equivalents

$246.38M
IART annual cash & cash equivalents is $246.38 million

Accounts receivable

$272.37M
IART annual accounts receivable is $272.37 million

Inventory

$429.09M
IART annual inventory is $429.09 million

Liabilities

Total liabilities

$2.49B
IART annual total liabilities is $2.49 billion

Long term liabilities

$1.57B
IART annual total long term liabilities is $1.57 billion

Current liabilities

$922.13M
IART annual total current liabilities is $922.13 million

Accounts payable

$82.50M
IART annual accounts payable is $82.50 million

Debt

Total debt

$1.98B
IART annual total debt is $1.98 billion

Total debt 1-year change

+18.01%
IART annual total debt is up +18.01% year-on-year

Long term debt

$1.36B
IART annual long term debt is $1.36 billion

Short term debt

$621.62M
IART annual short term debt is $621.62 million

Equity & Capital

Shareholders equity

$1.55B
IART annual stockholders equity is $1.55 billion

Book value

$1.55B
IART annual book value is $1.55 billion

Retained earnings

$939.91M
IART annual retained earnings is $939.91 million

Working capital

$159.56M
IART annual working capital is $159.56 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$129.38M
IART annual cash flow from operations is $129.38 million

Cash from operations 1-year change

-7.55%
IART annual cash flow from operations is down -7.55% year-on-year

Cash from investing

-$390.81M
IART annual cash flow from investing activities is -$390.81 million

Cash from investing 1-year change

-314.97%
IART annual cash flow from investing activities is down -314.97% year-on-year

Cash from financing

$237.86M
IART annual cash flow from financing activities is $237.86 million

Cash from financing 1-year change

+203.45%
IART annual cash flow from financing activities is up +203.45% year-on-year

CAPEX

CAPEX

$114.37M
IART annual capital expenditures is $114.37 million

CAPEX 1-year change

+71.05%
IART annual capital expenditures is up +71.05% year-on-year

Free Cash Flow

Free cash flow

$15.01M
IART annual free cash flow is $15.01 million

Free cash flow 1-year change

-79.46%
IART annual free cash flow is down -79.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

54.77%
IART annual gross profit margin is 54.77%

Operating margin

1.76%
IART annual operating profit margin is 1.76%

Net margin

-0.43%
IART annual net profit margin is -0.43%

ROA & ROE

ROA

-0.18%
IART annual return on assets is -0.18%

ROE

-0.44%
IART annual return on equity is -0.44%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IART price to earnings ratio value is unknown

PE ratio Sector rank

-
IART price to earnings ratio is unknown

PB Ratio

PB ratio

0.81
IART price to book ratio is 0.81

PB ratio Sector rank

40.58%
IART price to book ratio is higher than 40.58% of companies in Healthcare sector

PS Ratio

PS ratio

0.78
IART price to sales ratio is 0.78

PS ratio Sector rank

23.97%
IART price to sales ratio is higher than 23.97% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.99B
IART enterprise value is $2.99 billion

Enterprise value Sector rank

85.19%
IART enterprise value is higher than 85.19% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.45
IART EV/EBITDA is 15.45

EV/EBITDA Sector rank

88.34%
IART EV/EBITDA is higher than 88.34% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.17
IART annual current ratio is 1.17

Quick ratio

0.71
IART annual quick ratio is 0.71

Leverage

Debt to equity

1.17
IART annual debt to equity ratio is 1.17

Interest coverage ratio

0.74
IART annual interest coverage ratio is 0.74

Risk & Stability

Piotroski F-Score

4
IART piotroski f-score is 4

Altman Z-Score

1.12
IART altman z-score is 1.12

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Hold
Mar 31, 25 Argus Research
Buy
Feb 26, 25 Citizens Capital Markets
Market Outperform
Nov 5, 24 Citigroup
Sell
Oct 14, 24 Truist Securities
Hold
Oct 7, 24 BTIG
Neutral
Oct 7, 24 B of A Securities
Underperform
Oct 1, 24 Citigroup
Sell
Aug 28, 24 BTIG
Sell
Aug 22, 24 Citigroup
Sell

Institutional Ownership

Similar stocks

BKD logo
Brookdale Senior Living (BKD)
EWTX logo
Edgewise Therapeutics (EWTX)
TDOC logo
Teladoc Health (TDOC)
NEO logo
NeoGenomics (NEO)
CLDX logo
Celldex Therapeutics (CLDX)
OCUL logo
Ocular Therapeutix (OCUL)
EVO logo
Evotec SE (EVO)
AZTA logo
Azenta (AZTA)
TNDM logo
Tandem Diabetes Care (TNDM)
  • What is the ticker symbol for Integra LifeSciences Holdings?
  • Does Integra LifeSciences Holdings pay dividends?
  • What sector is Integra LifeSciences Holdings in?
  • What industry is Integra LifeSciences Holdings in?
  • What country is Integra LifeSciences Holdings based in?
  • When did Integra LifeSciences Holdings go public?
  • Is Integra LifeSciences Holdings in the S&P 500?
  • Is Integra LifeSciences Holdings in the NASDAQ 100?
  • Is Integra LifeSciences Holdings in the Dow Jones?
  • When was Integra LifeSciences Holdings's last earnings report?
  • When does Integra LifeSciences Holdings report earnings?
  • Should I buy Integra LifeSciences Holdings stock now?

What is the ticker symbol for Integra LifeSciences Holdings?

The ticker symbol for Integra LifeSciences Holdings is NASDAQ:IART

Does Integra LifeSciences Holdings pay dividends?

No, Integra LifeSciences Holdings does not pay dividends

What sector is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Healthcare sector

What industry is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Medical Devices industry

What country is Integra LifeSciences Holdings based in?

Integra LifeSciences Holdings is headquartered in United States

When did Integra LifeSciences Holdings go public?

Integra LifeSciences Holdings's initial public offering (IPO) was on August 16, 1995

Is Integra LifeSciences Holdings in the S&P 500?

No, Integra LifeSciences Holdings is not included in the S&P 500 index

Is Integra LifeSciences Holdings in the NASDAQ 100?

No, Integra LifeSciences Holdings is not included in the NASDAQ 100 index

Is Integra LifeSciences Holdings in the Dow Jones?

No, Integra LifeSciences Holdings is not included in the Dow Jones index

When was Integra LifeSciences Holdings's last earnings report?

Integra LifeSciences Holdings's most recent earnings report was on Feb 25, 2025

When does Integra LifeSciences Holdings report earnings?

The next expected earnings date for Integra LifeSciences Holdings is May 6, 2025

Should I buy Integra LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page